Trupanion, Inc. (LON:0LH0)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 990.85M -36.5% |
| Revenue (ttm) | 1.15B +11.8% |
| Net Income | 17.50M +110.8% |
| EPS | 0.40 +113.8% |
| Shares Out | n/a |
| PE Ratio | 56.63 |
| Forward PE | 7.70 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,506 |
| Open | 30.50 |
| Previous Close | 29.93 |
| Day's Range | 29.78 - 31.37 |
| 52-Week Range | 21.22 - 51.00 |
| Beta | 1.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About Trupanion
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. and changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington. [Read more]
News
Trupanion reports Q2 EPS 16c vs. 22c last year
Reports Q2 revenue $392.93M, consensus $389.72M. “We continue to execute on the priorities that matter most by growing margin, improving the economics of new enrollments, and investing our capital wit...
Trupanion announces $100M stock repurchase program
The board has authorized a share repurchase program, pursuant to which the company may repurchase up to an aggregate of $100M of its outstanding shares of common stock, with no…
Trupanion Earnings Call Transcript: Q2 2026
Q2 saw 24% growth in adjusted operating income, strong pet adds, and improved retention. Revenue and free cash flow rose year-over-year, with a $100 million share repurchase program announced. Guidance for 2026 was raised, reflecting confidence in continued growth.
Trupanion Earnings release: Q2 2026
Trupanion released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Trupanion Quarterly report: Q2 2026
Trupanion has published its Q2 2026 quarterly earnings report on August 5, 2026.
Trupanion Reports Second Quarter 2026 Results
SEATTLE, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended Jun...
Less Paperwork. More Pets.
SEATTLE, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Every minute matters in a veterinary hospital. But too often, valuable time is spent navigating paperwork and answering payment questions instead of focusing...
Trupanion Slides: Investor presentation
Trupanion has posted slides in relation to its latest quarterly earnings report, which was published on August 1, 2026.
Trupanion Announces Second Quarter 2026 Earnings Release and Conference Call
SEATTLE, July 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 second quarter...
Trupanion price target lowered to $42 from $52 at BofA
BofA lowered the firm’s price target on Trupanion (TRUP) to $42 from $52 and keeps a Buy rating on the shares. Q2 featured several notable catastrophe events globally, including windstorms…
Trupanion to Participate in Virtual Fireside Chat with Piper Sandler
SEATTLE, June 24, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today that Margi Tooth, Chief Executive Officer and President, wil...
Lacy Pushes Trupanion Past $4 Billion in Paid Claims, Helping More than 3.9 Million Pets Receive Care
After taking 20 years to reach its first $1 billion in paid claims, Trupanion surpassed $4 billion just 18 months after crossing $3 billion, highlighting the growing role of high-quality pet insurance...
Trupanion price target lowered to $52 from $59 at BofA
BofA lowered the firm’s price target on Trupanion (TRUP) to $52 from $59 and keeps a Buy rating on the shares. The firm’s 2026 EPS forecast rises with the Q1…
Trupanion reports Q1 EPS 11c vs. (3c) last year
Reports Q1 revenue $384M, consensus $379.77M. “The gap between the cost of veterinary care and what pet parents can reasonably plan for continues to widen,” said Margi Tooth, Chief Executive…
Trupanion Earnings Call Transcript: Q1 2026
Q1 2026 saw 29% year-over-year AOI growth, record subscription margins, and strong pet additions. Guidance for 2026 remains robust, with new product launches and expanded flexibility targeting broader segments. AOI is now the primary performance metric.
Trupanion Quarterly report: Q1 2026
Trupanion has published its Q1 2026 quarterly earnings report on April 30, 2026.
Trupanion Earnings release: Q1 2026
Trupanion released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Trupanion Reports First Quarter 2026 Results
SEATTLE, April 30, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended Mar...
Trupanion Publishes 2025 Annual Letter to Shareholders
SEATTLE, April 27, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, has published its 2025 annual shareholder letter from CEO and President, Ma...
Trupanion Proxy statement: Proxy filing
Trupanion filed a proxy statement on April 27, 2026, providing details for shareholder voting and corporate governance matters.
Trupanion Proxy statement: Proxy filing
Trupanion filed a proxy statement on April 27, 2026, providing details for shareholder voting and corporate governance matters.
Trupanion Announces First Quarter 2026 Earnings Release and Conference Call
SEATTLE, April 16, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2026 first quarter...
Trupanion price target lowered to $59 from $63 at BofA
BofA lowered the firm’s price target on Trupanion (TRUP) to $59 from $63 and keeps a Buy rating on the shares. The firm adjusted price target among its U.S. insurance…
Trupanion price target lowered to $34 from $42 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Trupanion (TRUP) to $34 from $42 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the…
Trupanion price target lowered to $31 from $35 at Stifel
Stifel analyst Jonathan Block lowered the firm’s price target on Trupanion (TRUP) to $31 from $35 and keeps a Hold rating on the shares after survey checks in the animal…